Metabolomic Technologies Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Metabolomic Technologies Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12141
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Metabolomic Technologies Inc (MTI) is a diagnostic company that develops metabolomic-based diagnostic systems. The company’s products comprise ColoDx, PolypDx, BreastDx, ProstateDx, CeliacDx, ColitisDx, CrohnsDx and other products. Its products develop advanced diagnostic tests for gastrointestinal diseases in their early stages. MTI’s products are used in the treatment of breast cancer, prostate cancer, celiac disease, ulcerative colitis, Crohn’s disease, IBD, lactose intolerance, acid reflux and gastric ulcers. The company provides metabolomics analysis for various applications including sample preparation, data collection, statistical analysis, and interpretation. It also conducts research and development programs to identify metabolomic fingerprints in urine samples. MTI is headquartered in Edmonton, Alberta, Canada.

Metabolomic Technologies Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Metabolomic Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Metabolomic Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Metabolomic Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Metabolomic Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Metabolomic Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Metabolomic Technologies Inc, Medical Equipment, Deal Details 10
Partnerships 10
Lab Express Enters into Licensing Agreement with Metabolomic Technologies 10
Atlantic Diagnostic Labs Enters into Licensing Agreement with Metabolomic Technologies 11
Metabolomic Technologies Enters Into Co-Development Agreement With BGI Shenzhen For PolypDx 12
Metabolomic Technologies Inc – Key Competitors 13
Metabolomic Technologies Inc – Key Employees 14
Metabolomic Technologies Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Metabolomic Technologies Inc, Medical Equipment, Key Facts 2
Metabolomic Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Metabolomic Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Metabolomic Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Metabolomic Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Metabolomic Technologies Inc, Deals By Market, 2012 to YTD 2018 8
Metabolomic Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Lab Express Enters into Licensing Agreement with Metabolomic Technologies 10
Atlantic Diagnostic Labs Enters into Licensing Agreement with Metabolomic Technologies 11
Metabolomic Technologies Enters Into Co-Development Agreement With BGI Shenzhen For PolypDx 12
Metabolomic Technologies Inc, Key Competitors 13
Metabolomic Technologies Inc, Key Employees 14

List of Figures
Metabolomic Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Metabolomic Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Metabolomic Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Metabolomic Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Metabolomic Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Metabolomic Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Metabolomic Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Metabolomic Technologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Metabolomic Technologies Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lamar Advertising Company:企業の戦略・SWOT・財務分析
    Lamar Advertising Company - Strategy, SWOT and Corporate Finance Report Summary Lamar Advertising Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Tenneco Inc. (TEN):企業の財務・戦略的SWOT分析
    Tenneco Inc. (TEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Entek Energy Ltd (ETE):石油・ガス:M&Aディール及び事業提携情報
    Summary Entek Energy Limited (Entek Energy) is an upstream energy company that carries out the exploration, production and development of oil and gas reserves in addition to investment in the energy resources industry. It acquires oil and gas assets and explores conventional and unconventional sourc …
  • Octapharma AG:企業の戦略・SWOT・財務情報
    Octapharma AG - Strategy, SWOT and Corporate Finance Report Summary Octapharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Worldpay, Inc.:企業の財務・戦略的SWOT分析
    Worldpay, Inc. - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Schroders plc:戦略・SWOT・企業財務分析
    Schroders plc - Strategy, SWOT and Corporate Finance Report Summary Schroders plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Anteo Diagnostics Ltd (ADO):企業の財務・戦略的SWOT分析
    Anteo Diagnostics Ltd (ADO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Nedbank Group Ltd (NED):企業の財務・戦略的SWOT分析
    Nedbank Group Ltd (NED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • First Derivatives plc (FDP):企業の財務・戦略的SWOT分析
    First Derivatives plc (FDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • WPP Plc (WPP):企業の財務・戦略的SWOT分析
    WPP Plc (WPP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Dentsply Sirona Inc (XRAY):医療機器:M&Aディール及び事業提携情報
    Summary Dentsply Sirona Inc (Dentsply Sirona) formerly Dentsply International Inc, is a medical device company that designs, develops, manufactures and markets a wide range of products for the dental market. It provides dental prosthetics, precious metal dental alloys, dental ceramics, endodontic in …
  • Putzmeister Holding GmbH:企業の戦略・SWOT・財務情報
    Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Texas Children’s Hospital:企業の戦略的SWOT分析
    Texas Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Aspen Technology, Inc. (AZPN):企業の財務・戦略的SWOT分析
    Aspen Technology, Inc. (AZPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Broadridge Financial Solutions, Inc. (BR):企業の財務・戦略的SWOT分析
    Broadridge Financial Solutions, Inc. (BR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Lear Corporation:企業の戦略・SWOT・財務情報
    Lear Corporation - Strategy, SWOT and Corporate Finance Report Summary Lear Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Unimedic AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Unimedic AB (Unimedic), formerly Ergobe Pharma AB, a subsidiary of MedCap AB, is a pharmaceutical company which develops, manufactures, distributes and markets pharmaceutical products. The company offers non-licensed, extemporaneous, and licensed pharmaceuticals targeting the therapy areas w …
  • Karur Vysya Bank Ltd:企業の戦略・SWOT・財務情報
    Karur Vysya Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Karur Vysya Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hammerhead Resources Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Hammerhead Resources Inc (Hammerhead Resources), formerly Canadian International Oil Corp is an oil and gas company that offers oilfield services. The company offers services such as acquisition, production, operations, exploration, management, and development of oil and gas assets in North …
  • Supernus Pharmaceuticals Inc (SUPN)-製薬・医療分野:企業M&A・提携分析
    Summary Supernus Pharmaceuticals Inc (Supernus) is a specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company's neurology portfolio consists of Oxtellar XR (oxcarbazepine), an adjunct therapy for the treatment …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆